Galapagos NV (GLPG) Dividends
There have not been any declared dividends recently.
|Previous Dividend||Next Dividend|
|Your Holding:||100 shares||100 shares|
Dividend Payment Calculator
Enter the number of shares you hold:
Free dividend email notifications
Receive an email whenever Galapagos NV declares a dividend:
Declared and Forecast Galapagos NV Dividends
|Ex-Div Date||Pay Date||Type||Amount||Currency||Status|
|There are no Galapagos NV dividends.|
Access our Galapagos NV dividend forecasts and the suite of investor tools free for 30 days.Try DividendMax free for 30 days
About Galapagos NV
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biotechnology company, focused on the development and commercialization of novel medicines that will improve people's lives.
Galapagos develops therapies with proprietary, novel modes-of-action. Filgotinib, Galapagos' most advanced novel mode-of-action program, was discovered using our proprietary target discovery technology, and is being developed by Gielad in Phase 3 in rheumatoid arthritis, Crohn's disease and ulcerative colitis. Galapagos is progressing multiple programs in inflammation, cystic fibrosis, metabolic diseases, fibrosis, and other disease areas.
Galapagos is listed on Euronext Amsterdam and Brussels and on the NASDAQ; all with the ticker symbol GLPG.
|Ex-Div Date||Pay Date||Year||Type||Frequency||Status||Amount|